| Ytd | -60.21% | |
| 1y | -73.16% |
| Open | 0.59 | Prev Close | 0.61 | Low | 0.56 | High | 0.59 | Mkt Cap | 1.59M |
| Vol | 89.87K | Avg Vol | 331.13K | EPS | -0.28 | P/E | N/A | Forward P/E | -0.41 |
| Beta | 0.74 | Short Ratio | 0.18 | Inst. Own | 4.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.04 | 200-d Avg | 1.33 | 1yr Est | 16.75 |
BBLG News
Gainers Veeva Systems (NYSE:VEEV) shares increased by 8.7% to $266.15 during Wednesday's after-
Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market
Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular sess
Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 17.7% to $1.07 during Wednesday's p
BURLINGTON, Mass, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or
Bone Biologics (NASDAQ: BBLG - Get Free Report) will likely be issuing its results before the market
BURLINGTON, Mass, July 23, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW)
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's afte
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 95.7% to $1.4 during Wednesday's
Gainers Catheter Precision (AMEX:VTAK) shares moved upwards by 55.8% to $1.11 during Wednesday'
iOThree Ltd (IOTR) rose in premarket trading after strong fiscal 2026 results. Gainers include EDBL,
$3.0 million upfront with up to approximately $6.0 million of potential additional gross proceeds up
Gainers Catheter Precision (AMEX:VTAK) shares rose 78.2% to $1.55 during Monday's after-market
href=https://www.benzinga.com/quote/RMSG target=_blank>(NASDAQ: RMSG) lost 67.6% to $0.69 in
The updated shelf life is supported by continued third-party stability data. The additional five mon
Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.43) per share which beat the analyst c
https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_03032026_BBLG_Sorensen.pdf
Key accomplishments include expanded rhNELL-1 shelf life, advanced NB1 development, strengthened bal
Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ:BBLG, BBLGW))
Milestone advances manufacturing readiness and supports long-term commercialization strategy Milesto
Bone Biologics Corp. (NASDAQ: BBLG - Get Free Report)'s share price fell 0.5% during trading on Wedn
https://s27.q4cdn.com/906368049/files/News/2025/Zacks_SCR_Research_11172025_BBLG_Sorensen.pdf
One-Year OutlookThe firm expect to achieve a number of value-creating events in the coming year unde
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(1.33) per share which missed the analyst
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
Bone Biologics Corporation BBLG stock is trading higher on Friday, with a session volume of 17.22 mi
Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials
Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ:BBLG, BBLGW))
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
BURLINGTON, Mass.--(BUSINESS WIRE)---- $BBLG #Bonebiologics--Bone Biologics files U.S. patent applic
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (